Virginia Commonwealth University Health System Hematology and Medical Oncology

Topics

• CAR-T cell therapy research 67
• Hematopoietic Stem Cell Transplantation 66
• Lymphoma Diagnosis and Treatment 56
• Acute Myeloid Leukemia Research 51
• Multiple Myeloma Research and Treatments 51
• Cancer Immunotherapy and Biomarkers 30
• Lung Cancer Treatments and Mutations 26
• Sarcoma Diagnosis and Treatment 23
• Childhood Cancer Survivors' Quality of Life 22
• Lung Cancer Diagnosis and Treatment 17
• Palliative Care and End-of-Life Issues 17
• Histone Deacetylase Inhibitors Research 16

Most cited

1. Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.

   The New England journal of medicine · 2023 · 739 citations · Andrew Poklepovic

2. Palliative Care for Patients With Cancer: ASCO Guideline Update.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 279 citations · Erin Alesi

3. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 813 citations · Renato Martins

4. Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma.

   Blood · 2025 · 135 citations · Hashim Mann

5. Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults.

   The New England journal of medicine · 2024 · 235 citations · Shejal Patel

6. Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial.

   Lancet (London, England) · 2022 · 443 citations · Andrew Poklepovic